Testimony Before the FDA’s Psychopharmacologic Drugs Advisory Committee Regarding Gepirone

View PDF: Summary | Presentation

Public Citizen strongly opposes Food and Drug Administration (FDA) approval of gepirone for treatment of depression. The drug showed such poor results in clinical testing that its approval by the FDA would effectively weaken standards for approval of new antidepressants.